1. Malaysia Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
DSwiss, Inc.

DSwiss, Inc.

DQWS
DSwiss, Inc.US flagOther OTC
0.03
USD
- -
- -
6.41MMarket Cap
DSwiss, Inc.
DQWS
(Other OTC)

Recent

price

0.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
0.01
0.01
0.01
0.01
0.02
0.01
0.01
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
207
207
206
207
207
207
207
207
207
207
207
207
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
2
2
1
3
3
2
Sales/Revenue/Turnover
-83.52
-376.17
-157.59
-172.36
-127.74
2.45
7.38
-0.06
-3.6
0.59
-2.97
-9.1
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
9.54
0.12
- -
- -
26.17
- -
44.64
Effective Tax Rate (%)
-83.43
-376.16
-157.05
-159.6
-104.47
0.57
8.86
-0.77
-3.37
0.71
-2.63
-8.81
Profit Margin (%)
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
102.6
110.02
- -
- -
9.89
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
0.7
-16.16
- -
- -
-1.79
- -
7.11
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
207
207
207
Market Capitalization
6
8
18

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-36.89%
-59.55%
-112.62%
Free Cash Flow
64.63%
78.25%
-275.74%
Net Income, GAAP
186.4%
341.54%
-445.86%
Sales/Revenue/Turnover
58.37%
24.96%
-6.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
1
1
1
3
2025
1
1
- -
- -
3
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Natura &Co Holding S.A. (NTCO)
Almado, Inc. (4932.T)
Leaders Cosmetics Co., Ltd. (016100.KQ)
Unicharm Corporation (UNICY)
Skin Elements Limited (SKN.AX)
MTG Co., Ltd. (7806.T)
Business
DSwiss, Inc. (DQWS) operates as a biotech nutraceutical company focused on healthcare, skincare, personal care, and related products; it supplies high-quality health supplements including weight management beverages, anti-aging creams, and immune system enhancers; skincare solutions; pet wellness supplements and pet-care products; medical consumable supplies; alongside private label manufacturing services for nutraceutical, skincare, and personal care ODM/OEM products; OEM/ODM/OBM services; and biotechnology research channel services such as the DSwiss Quantum Magnetic Analyzer. The company serves consumer markets in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China from its headquarters in Kuala Lumpur, Malaysia, where it was incorporated in 2015 as a Nevada corporation operating through its wholly-owned subsidiary DSwiss Holding Limited in Seychelles. Recent developments include ongoing private label manufacturing expansions and biotechnology service enhancements as detailed in its latest SEC 10-K filing for the year ended December 31, 2024, with no major acquisitions, partnerships, or funding rounds announced in the past 1-2 years.